PharmGKB contains no dosing guidelines for this drug/small molecule. To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.
PharmGKB contains no drug labels with pharmacogenomic information for this drug/small molecule. To report a drug label with PGx, click here.
PharmGKB contains no clinical annotations for this drug/small molecule. To report clinical variants, click here.
PharmGKB contains no genetic testing information for this drug/small molecule. To report genetic tests, click here.
Overview
Generic Names
Trade Names
Brand Mixture Names
PharmGKB Accession Id:
PA165947499
ATC Therapeutic Category
- A02BC:Proton pump inhibitors
Information pulled from DrugBank has not been reviewed by PharmGKB.
Chemical Properties
IUPAC Names
- 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1H-benzimidazole
Publications related to ilaprazole: 1
|
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5. Xenobiotica; the fate of foreign compounds in biological systems. 2011. Seo Kyung-Ah, et al. [Article:22022918@PubMed] |